Shilpa Medicare Limited has informed the Exchange regarding a press release, titled "Press release on announcement of commissioning of a state-of-art Antibody Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals Private Ltd, a material subsidiary of Shilpa Medicare Ltd.".
Shilpa Medicare Limited Press Release Jun 24 2026
Earlier from Shilpa Medicare
- Press Release Jun 03 2026
- SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
- Press Release Feb 24 2026
- Press Release Jan 28 2026